CastleKnight Management LP bought a new stake in shares of MultiPlan Co. (NYSE:MPLN - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 224,229 shares of the company's stock, valued at approximately $3,314,000. CastleKnight Management LP owned about 1.39% of MultiPlan as of its most recent filing with the SEC.
A number of other institutional investors have also recently bought and sold shares of MPLN. Northern Trust Corp raised its holdings in MultiPlan by 5.5% during the 4th quarter. Northern Trust Corp now owns 14,335 shares of the company's stock worth $212,000 after buying an additional 747 shares during the period. XTX Topco Ltd bought a new stake in shares of MultiPlan in the fourth quarter valued at about $225,000. Oppenheimer & Co. Inc. bought a new position in shares of MultiPlan during the fourth quarter worth about $292,000. Jane Street Group LLC lifted its stake in MultiPlan by 14.4% in the 4th quarter. Jane Street Group LLC now owns 19,985 shares of the company's stock valued at $295,000 after acquiring an additional 2,512 shares in the last quarter. Finally, Walleye Capital LLC acquired a new position in MultiPlan during the 4th quarter worth approximately $359,000. Institutional investors and hedge funds own 87.15% of the company's stock.
MultiPlan Stock Up 0.4 %
MultiPlan stock traded up $0.09 during mid-day trading on Friday, reaching $21.67. The company's stock had a trading volume of 40,671 shares, compared to its average volume of 116,350. MultiPlan Co. has a 12 month low of $4.80 and a 12 month high of $30.62. The company has a market capitalization of $350.43 million, a price-to-earnings ratio of -0.23 and a beta of 0.13. The company has a debt-to-equity ratio of 21.73, a quick ratio of 1.05 and a current ratio of 1.05. The business's 50 day simple moving average is $20.58 and its 200 day simple moving average is $16.13.
MultiPlan Profile
(
Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Articles
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
